Drug Trial Radar · NCT01114139
A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia
Last checked: Nov 20, 2026Latest source record: Apr 21, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
812
Actual
Start
Jun 19, 2010
Primary completion
Feb 27, 2012
Study completion Oct 22, 2012
Sponsor
- Lead sponsor
- AMAG Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 30, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy and safety of intravenous (IV) ferumoxytol compared with placebo for the treatment of iron deficiency anemia (IDA).
Conditions
- Iron Deficiency Anemia
Interventions
FerumoxytolDrug
IV Ferumoxytol
PlaceboOther
IV Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Participants Who Achieved A ≥2.0 g/dL Increase In Hemoglobin At Any Time From Baseline To Week 5Time frame: Baseline (Day 1) through Week 5
Locations
182 sites in 6 countries. Site status is shown where the registry gives one.
Clinical Trial Site
Birmingham, Alabama
Clinical Trial Site
Mobile, Alabama
Clinical Trial Site
Montgomery, Alabama
Clinical Trial Site
Montgomery, Alabama
Clinical Trial Site
Green Valley, Arizona
Clinical Trial Site
Phoenix, Arizona
Clinical Trial Site
Phoenix, Arizona
Clinical Trial Site
Tucson, Arizona
Clinical Trial Site
Tucson, Arizona
Clinical Trial Site
Alhambra, California
Clinical Trial Site
Anaheim, California
Clinical Trial Site
Bakersfield, California
Clinical Trial Site
Buena Park, California
Clinical Trial Site
Colton, California
Clinical Trial Site
Fresno, California
Clinical Trial Site
Glendale, California
Clinical Trial Site
Laguna Hills, California
Clinical Trial Site
Laguna Hills, California
Clinical Trial Site
Lakewood, California
Clinical Trial Site
Los Angeles, California
Clinical Trial Site
Los Angeles, California
Clinical Trial Site
Los Angeles, California
Clinical Trial Site
Mission Hills, California
Clinical Trial Site
Orange, California
Clinical Trial Site
San Diego, California
Clinical Trial Site
San Diego, California
Clinical Trial Site
San Diego, California
Clinical Trial Site
Pueblo, Colorado
Clinical Trial Site
Bristol, Connecticut
Clinical Trial Site
Groton, Connecticut
Clinical Trial Site
Newark, Delaware
Clinical Trial Site
Boynton Beach, Florida
Clinical Trial Site
Boynton Beach, Florida
Clinical Trial Site
Clearwater, Florida
Clinical Trial Site
Clearwater, Florida
Clinical Trial Site
Hialeah, Florida
Clinical Trial Site
Holiday, Florida
Clinical Trial Site
Inverness, Florida
Clinical Trial Site
Margate, Florida
Clinical Trial Site
Miami, Florida
Showing 40 of 182 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.